போஹெரிங்கர் இஂகல்ஹைம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
xCures raises $12 69 million in Series A funding for their AI-powered precision oncology platform
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Search jobs 26-Apr-2021 Virology Market 2021 Size, Industry Share, Growth, Trends, Scope, Opportunity Analysis and Industry Forecast by 2025 | GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation & so on…
Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Virology Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period.
Impact of COVID-19 on the Healthcare Industry
The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units,